“In vivo, CLA administration drastically reduced SLE signs (splenomegaly, autoantibodies, and cytokine synthesis), a condition paralleled by the enhancement of GCLC expression and intracellular GSH content.”
“… CLA exerted apparently opposed activities in in vitro experiments, depending on its concentration: 100 microM … proliferation of splenocytes, in association with apoptosis induction and a decrease of intracellular thiols ( GSH + GSSG), whereas 25 microM CLA did not significantly influence cell …-glutamylcysteine ligase catalytic subunit (GCLC) and intracellular GSH concentration.”